{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:25Z","timestamp":1786984225386,"version":"build-2736575974"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajpc.2025.101357","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T07:51:59Z","timestamp":1763797919000},"page":"101357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights"],"prefix":"10.1016","volume":"24","author":[{"given":"Annalisa","family":"Filtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K","family":"Whelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Navar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Blankstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde W","family":"Yancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3091-3735","authenticated-orcid":false,"given":"Leandro","family":"Slipczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S8","key":"10.1016\/j.ajpc.2025.101357_bib0001","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/dom.16469","article-title":"How and in whom should we measure levels of lipoprotein(a): a review of the latest evidence and clinical implications","volume":"27","author":"Razavi","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0002","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arter Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101357_bib0004","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of Cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101357_bib0005","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101357_bib0006","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurjpc\/zwae341","article-title":"Intra-individual variability in lipoprotein(a) levels: findings from a large academic health system population","volume":"32","author":"Awad","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101357_bib0007","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2021.11.053","article-title":"Measurement of lipoprotein(a): a once in a lifetime opportunity","volume":"79","author":"Marcovina","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101357_bib0008","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCULATIONAHA.123.066398","article-title":"Relating lipoprotein(a) concentrations to cardiovascular event risk after acute coronary syndrome: a comparison of 3 tests","volume":"149","author":"Szarek","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jacl.2024.11.007","article-title":"Lipoprotein(a) levels in a population with clinical atherosclerotic cardiovascular disease in the United States: a subanalysis from the Lp(a)HERITAGE study","volume":"19","author":"Shapiro","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arter Thromb Vasc Biol"},{"issue":"27","key":"10.1016\/j.ajpc.2025.101357_bib0011","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/eurheartj\/ehaf207","article-title":"ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease","volume":"46","author":"Morze","year":"2025","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101357_bib0012","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/cvr\/cvab060","article-title":"Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein(a)","volume":"117","author":"Trinder","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpc.2025.101357_bib0013","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2022.10.004","article-title":"Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"363","author":"Rikhi","year":"2022","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101357_bib0014","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101357_bib0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCULATIONAHA.124.069556","article-title":"Independence of lipoprotein(a) and low-density lipoprotein cholesterol-mediated cardiovascular risk: a participant-level meta-analysis","volume":"151","author":"Bhatia","year":"2025","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101357_bib0016","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O\u2019Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101357_bib0017","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jacc.2021.04.102","article-title":"Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol","volume":"78","author":"Schwartz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101357_bib0018","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/eurjpc\/zwae382","article-title":"Traditional risk factors, optimal cardiovascular health, and elevated lipoprotein(a)","volume":"32","author":"Razavi","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"14","key":"10.1016\/j.ajpc.2025.101357_bib0019","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2022.07.027","article-title":"Aspirin for primary prevention of cardiovascular events in relation to lipoprotein(a) genotypes","volume":"80","author":"Lacaze","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101357_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pcad.2025.03.009","article-title":"Refining cardiovascular risk assessment: the interplay of lipoprotein (a) and waist-to-hip ratio","volume":"89","author":"Filtz","year":"2025","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101357_bib0021","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101357_bib0022","first-page":"2329","article-title":"Optimal antihypertensive systolic blood pressure: a systematic review and meta-analysis","volume":"81","author":"Whelton","year":"2024","journal-title":"Hypertens Dallas Tex 1979"},{"key":"10.1016\/j.ajpc.2025.101357_bib0023","doi-asserted-by":"crossref","unstructured":"Writing Committee Members*, Jones D.W., Ferdinand K.C., et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertens Dallas Tex 1979 2025;82(10):e212\u2013316. https:\/\/doi.org\/10.1161\/HYP.0000000000000249.","DOI":"10.1161\/HYP.0000000000000249"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101357_bib0024","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamacardio.2021.5083","article-title":"Association of apolipoprotein B-containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis: distinguishing between particle concentration, type, and content","volume":"7","author":"Marston","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101357_bib0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamacardio.2024.1310","article-title":"Individual variation in the distribution of apolipoprotein B levels across the spectrum of LDL-C or non-HDL-C levels","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0026","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.124.068885","article-title":"Apolipoprotein B: bridging the gap between evidence and clinical practice","volume":"150","author":"De Oliveira-Gomes","year":"2024","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101357_bib0027","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood Cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101357_bib0028","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCULATIONAHA.122.062746","article-title":"Incidental coronary artery calcium: opportunistic screening of previous nongated chest computed tomography scans to improve statin rates (NOTIFY-1 Project)","volume":"147","author":"Sandhu","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101357_bib0029","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ahj.2024.09.005","article-title":"Enrollment strategies in the era of digital revolution: experience from a remote health management program","volume":"278","author":"Hassan","year":"2024","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101357_bib0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41569-021-00522-7","article-title":"Smart wearable devices in cardiovascular care: where we are and how to move forward","volume":"18","author":"Bayoumy","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpc.2025.101357_bib0031","article-title":"Access to digital health technologies: personalized framework and global perspectives","author":"Narayan","year":"2025","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12170-022-00711-0","article-title":"Health techequity: opportunities for digital Health innovations to improve equity and diversity in cardiovascular care","volume":"17","author":"Hernandez","year":"2023","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5334\/gh.1141","article-title":"World Heart Federation roadmap for digital health in cardiology","volume":"17","author":"Tromp","year":"2022","journal-title":"Glob Heart"},{"issue":"22","key":"10.1016\/j.ajpc.2025.101357_bib0034","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/CIRCULATIONAHA.124.068243","article-title":"Centennial Collection: health applications of Digital technologies","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ajpc.2025.101357_bib0035","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1161\/CIR.0000000000001314","article-title":"Role of technology in promoting Heart healthy behavior change to increase equity in optimal cardiovascular health: a scientific statement from the American Heart Association","volume":"151","author":"Powell-Wiley","year":"2025","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101357_bib0036","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2022.10.006","article-title":"Grains of sand to clinical pearls: realizing the potential of wearable data","volume":"136","author":"Seneviratne","year":"2023","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101357_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033328","article-title":"Comprehensive cardiovascular risk factor control with a mobile health cardiovascular risk self-management program","volume":"13","author":"Paz","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.53499","article-title":"Rehabilitation at home using mobile health for older adults hospitalized for ischemic heart disease: the RESILIENT randomized clinical trial","volume":"8","author":"Dodson","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101357_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030654","article-title":"Rationale and design of the mTECH-Rehab randomized controlled trial: impact of a mobile technology enabled Corrie cardiac rehabilitation program on functional status and cardiovascular health","volume":"13","author":"Isakadze","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101357_bib0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamacardio.2025.1013","article-title":"Reimbursement transformation is essential for digital health adoption in cardiovascular care","volume":"10","author":"Connolly","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101357_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100379","article-title":"Medicine 2032: the future of cardiovascular disease prevention with machine learning and digital health technology","volume":"12","author":"Javaid","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101357_bib0042","article-title":"2019 ACC\/AHA Guideline on the primary prevention of Cardiovascular Disease: executive Summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101357_bib0043","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101357_bib0044","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/eurheartj\/ehad539","article-title":"Recommendations for statin management in primary prevention: disparities among international risk scores","volume":"45","author":"Mancini","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/jcm12010075","article-title":"Cardiovascular outcomes of ST-elevation myocardial infarction (STEMI) patients without standard modifiable risk factors (SMuRF-Less): the Intermountain Healthcare experience","volume":"12","author":"Anderson","year":"2022","journal-title":"J Clin Med"},{"issue":"17","key":"10.1016\/j.ajpc.2025.101357_bib0046","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1177\/2047487317720287","article-title":"Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors","volume":"24","author":"Vernon","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0047","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002733","article-title":"Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention","volume":"11","author":"Ball","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.ajpc.2025.101357_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100504","article-title":"Saving women\u2019s hearts: improving outcomes with prevention & policy","volume":"14","author":"Gulati","year":"2023","journal-title":"Am J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101357_bib0049","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.116.025303","article-title":"Improving the cardiovascular health of women in the nation: moving beyond the bikini boundaries","volume":"135","author":"Gulati","year":"2017","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101357_bib0050","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1161\/CIR.0000000000000582","volume":"137","author":"Brown","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101357_bib0051","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019589","article-title":"Prognostic utility of risk enhancers and coronary artery calcium score recommended in the 2018 ACC\/AHA multisociety cholesterol treatment guidelines over the pooled cohort equation: insights from 3 large prospective cohorts","volume":"10","author":"Akintoye","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.ajpc.2025.101357_bib0052","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101357_bib0053","first-page":"ehaf209","article-title":"Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study","author":"Kraaijenhof","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101357_bib0054","doi-asserted-by":"crossref","first-page":"ehaf658","DOI":"10.1093\/eurheartj\/ehaf658","article-title":"C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors: evaluating the \u201cSMuRF-less but inflamed","author":"Ridker","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101357_bib0055","first-page":"ehaf589","article-title":"Strengthening the case for earlier LDL cholesterol lowering","author":"Post","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101357_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100711","article-title":"Relationship between epicardial adipose tissue and coronary atherosclerosis by CCTA in young adults (18\u201345)","volume":"19","author":"Filtz","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2025.101357_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100992","article-title":"Performance of PREVENT equations for cardiovascular risk prediction in young patients with myocardial infarction: from the MGB YOUNG-MI registry","volume":"22","author":"Singh","year":"2025","journal-title":"Am J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101357_bib0058","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2017.11.007","article-title":"Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry","volume":"71","author":"Singh","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101357_bib0059","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7440","article-title":"Association of coronary artery calcium with long-term, cause-specific mortality among young adults","volume":"2","author":"Miedema","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101357_bib0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2016.5493","article-title":"Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death","volume":"2","author":"Carr","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"20","key":"10.1016\/j.ajpc.2025.101357_bib0061","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.2023.7575","article-title":"Coronary artery calcium score and polygenic risk score for the prediction of Coronary heart disease events","volume":"329","author":"Khan","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101357_bib0062","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcmg.2017.01.030","article-title":"The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101357_bib0063","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jcmg.2023.03.007","article-title":"Impact of patient visualization of cardiovascular images on modification of cardiovascular risk factors: systematic review and meta-analysis","volume":"16","author":"Whitmore","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"10.1016\/j.ajpc.2025.101357_bib0064","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2025.0584","article-title":"Effects of combining coronary calcium score with treatment on plaque progression in familial coronary artery disease: a randomized clinical trial","volume":"333","author":"Nerlekar","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101357_bib0065","doi-asserted-by":"crossref","first-page":"zwae246","DOI":"10.1093\/eurjpc\/zwae246","article-title":"Sex disparities in statin use following coronary computed tomography angiography","author":"Filtz","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101357_bib0066","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamacardio.2022.4466","article-title":"Predictive utility of a coronary artery disease polygenic risk score in primary prevention","volume":"8","author":"Marston","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101357_bib0067","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0002-9149(03)00892-0","article-title":"Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction","volume":"92","author":"Raggi","year":"2003","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101357_bib0068","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/cvr\/cvaa184","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results","volume":"117","author":"Budoff","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101357_bib0069","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamacardio.2023.5661","article-title":"Effects of pitavastatin on coronary artery disease and inflammatory biomarkers in HIV: mechanistic substudy of the REPRIEVE randomized clinical trial","volume":"9","author":"Lu","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101357_bib0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jcmg.2025.01.005","article-title":"Effects of Evolocumab on coronary plaque composition and microcalcification activity by coronary PET and CT angiography","volume":"18","author":"Han","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101357_bib0071","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","article-title":"Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up","volume":"66","author":"Motoyama","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0072","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2021.10.035","article-title":"Coronary atherosclerotic plaque regression: JACC State-of-the-art review","volume":"79","author":"Dawson","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101357_bib0073","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2022.01.017","article-title":"Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial","volume":"248","author":"Sidhu","year":"2022","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101357_bib0074","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/ehjci\/jeae257","article-title":"Cardiac radiation exposure and incident cancer: challenges and opportunities","volume":"25","author":"Picano","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101357_bib0075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.123.064566","article-title":"Long-term mortality in patients with severe hypercholesterolemia phenotype from a racial and ethnically diverse US cohort","volume":"149","author":"Miles","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101357_bib0076","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa2415879","article-title":"Global effect of cardiovascular risk factors on lifetime estimates","volume":"393","author":"Consortium","year":"2025","journal-title":"N Engl J Med"},{"issue":"44","key":"10.1016\/j.ajpc.2025.101357_bib0077","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehae565","article-title":"Universal screening for hsCRP in patients with atherosclerotic disease: a major therapeutic opportunity","volume":"45","author":"Liuzzo","year":"2024","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101357_bib0078","article-title":"Statins for the \u201cSMuRFLess but inflamed\u201d: silent vascular inflammation and the challenge of translational science","volume":"10","author":"Ridker","year":"2025","journal-title":"JACC Basic Transl Sci"},{"issue":"10384","key":"10.1016\/j.ajpc.2025.101357_bib0079","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet L Engl"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.123.066213","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among 13\u2009970 contemporary high-risk patients with Statin intolerance","volume":"149","author":"Ridker","year":"2024","journal-title":"Circulation"},{"issue":"32","key":"10.1016\/j.ajpc.2025.101357_bib0081","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention\u2020","volume":"46","author":"Bay","year":"2025","journal-title":"Eur Heart J"},{"issue":"44","key":"10.1016\/j.ajpc.2025.101357_bib0082","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1093\/eurheartj\/ehae557","article-title":"Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease","volume":"45","author":"Mazhar","year":"2024","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.ajpc.2025.101357_bib0083","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.124.071269","volume":"151","author":"Steg","year":"2025","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ajpc.2025.101357_bib0084","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101357_bib0085","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101357_bib0086","doi-asserted-by":"crossref","first-page":"zwaf332","DOI":"10.1093\/eurjpc\/zwaf332","article-title":"Colchicine for secondary prevention in established ASCVD: a systematic review and meta-analysis","author":"Abdelaziz","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101357_bib0087","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa1803180","article-title":"Effect of systolic and diastolic blood pressure on cardiovascular outcomes","volume":"381","author":"Flint","year":"2019","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ajpc.2025.101357_bib0088","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial","volume":"126","author":"Esler","year":"2012","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ajpc.2025.101357_bib0089","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"issue":"10361","key":"10.1016\/j.ajpc.2025.101357_bib0090","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(22)01787-1","article-title":"Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial","volume":"400","author":"Bhatt","year":"2022","journal-title":"Lancet L Engl"},{"issue":"10234","key":"10.1016\/j.ajpc.2025.101357_bib0091","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet L Engl"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0092","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ahj.2015.08.021","article-title":"The SPYRAL HTN Global Clinical Trial Program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications","volume":"171","author":"Kandzari","year":"2016","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101357_bib0093","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.125.015194","article-title":"Long-term safety and efficacy of renal denervation: 24-month results from the SPYRAL HTN-ON MED trial","volume":"18","author":"Kandzari","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ajpc.2025.101357_bib0094","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2017.09.006","article-title":"A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: the RADIANCE-HTN and REQUIRE clinical study designs","volume":"195","author":"Mauri","year":"2018","journal-title":"Am Heart J"},{"issue":"10293","key":"10.1016\/j.ajpc.2025.101357_bib0095","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet L Engl"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101357_bib0096","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101357_bib0097","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCULATIONAHA.123.066941","article-title":"Patient-level pooled analysis of endovascular ultrasound renal denervation or a sham procedure 6 months after medication escalation: the RADIANCE Clinical Trial Program","volume":"149","author":"Azizi","year":"2024","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101357_bib0098","first-page":"602","article-title":"Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications","volume":"19","author":"Pathak","year":"2023","journal-title":"EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101357_bib0099","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.124.069291","article-title":"Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial","volume":"149","author":"Kandzari","year":"2024","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ajpc.2025.101357_bib0100","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.124.069709","article-title":"Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis","volume":"150","author":"Vukadinovi\u0107","year":"2024","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101357_bib0101","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","article-title":"Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community","volume":"115","author":"Ammar","year":"2007","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ajpc.2025.101357_bib0102","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101357_bib0103","doi-asserted-by":"crossref","unstructured":"SPRINT Research Group, Wright J.T., Williamson J.D., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373(22):2103\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1511939.","DOI":"10.1056\/NEJMoa1511939"},{"issue":"10166","key":"10.1016\/j.ajpc.2025.101357_bib0104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet L Engl"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101357_bib0105","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101357_bib0106","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101357_bib0107","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCGEN.120.003031","article-title":"Implications of genetic testing in dilated cardiomyopathy","volume":"13","author":"Verdonschot","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101357_bib0108","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41746-024-01308-0","article-title":"Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction","volume":"7","author":"Naghavi","year":"2024","journal-title":"NPJ Digit Med"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725004325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725004325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:48:18Z","timestamp":1765446498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725004325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":108,"alternative-id":["S2666667725004325"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101357","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101357"}}